Global Drug Screening Market Report 2017-2025 - Increase in Drug & Alcohol Abuse is a Major Driver -

The Global Drug Screening Market is poised to grow strong during the forecast period 2017 to 2025. Some of the prominent trends that the market is witnessing include increase in global population, regulations making drug and alcohol testing mandatory and increase in drug and alcohol abuse.

This industry report analyzes the market estimates and forecasts of all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2014, 2015 revenue estimations are presented for 2016 and forecasts from 2017 till 2025.

The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East, Latin America and Rest of the world the report is a valuable asset for the existing players, new entrants and the future investors.

Key Topics Covered

1 Market Outline

2 Executive Summary

3 Market Overview

4 Drug Screening Market, by Sample Type

5 Drug Screening Market, by End User

6 Drug Screening Market, by Products and Services

7 Drug Screening Market, by Geography

8 Key Player Activities

9 Leading Companies

  • Laboratory Corporation of America Holdings (Labcorp)
  • Quest Diagnostics Incorporated
  • Roche Diagnostics (A Division of F. Hoffmann-La Roche Ltd.)
  • Siemens Healthcare (A Subsidiary of Siemens Ag)
  • Thermo Fisher Scientific, Inc.
  • Shimadzu Corporation
  • MPD, Inc.
  • Alfa Scientific Designs, Inc.
  • Bio-Rad Inc.
  • Drgerwerk AG & Co. KGaA
  • Synergy Health PL
  • Express Diagnostics Int'l, Inc.
  • CannAmm Occupational Testing Services
  • Eiken Chemical
  • BioMerieux

For more information about this report visit

Back to news